Literature DB >> 10362532

Functional domains of template-activating factor-I as a protein phosphatase 2A inhibitor.

S Saito1, M Miyaji-Yamaguchi, T Shimoyama, K Nagata.   

Abstract

Template-Activating Factor-I (TAF-I) alpha and beta, chromatin remodeling factors, were identified as the stimulatory factor for replication of the adenovirus DNA complexed with viral basic core proteins. Recently, two cellular inhibitors for protein phosphatase 2A (PP2A) have been isolated. One of these inhibitors, designated IPP2A2, is a truncated version of TAF-Ibeta. Here, it is shown using recombinant TAF-I proteins that both TAF-Ialpha and beta have the PP2A inhibitor activity. The N-terminal region but not the C-terminal acidic region, the latter of which is essential for the chromatin remodeling activity, is shown to be required for the PP2A inhibitor activity. Roles of TAF-Ialpha- and beta-specific regions, the C-terminal acidic region, and other regions of TAF-I for the PP2A inhibitor activity are also discussed. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362532     DOI: 10.1006/bbrc.1999.0790

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Expression of Set-alpha during morphogenesis of mouse lower first molar.

Authors:  H Yamaza; K Matsuo; I Kobayashi; H Wada; T Kiyoshima; M Akhtar; Y Ishibashi; T Sakai; A Akamine; H Sakai
Journal:  Histochem J       Date:  2001-08

2.  Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock.

Authors:  I E Gallouzi; C M Brennan; J A Steitz
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

3.  The N-terminal Set-β Protein Isoform Induces Neuronal Death.

Authors:  Ephraim F Trakhtenberg; Melina I Morkin; Karan H Patel; Stephanie G Fernandez; Alan Sang; Peter Shaw; Xiongfei Liu; Yan Wang; Gregory M Mlacker; Han Gao; Dmitry Velmeshev; Susan M Dombrowski; Michael P Vitek; Jeffrey L Goldberg
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

4.  The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates.

Authors:  Matthew J Gamble; Hediye Erdjument-Bromage; Paul Tempst; Leonard P Freedman; Robert P Fisher
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Regulating Set-β's Subcellular Localization Toggles Its Function between Inhibiting and Promoting Axon Growth and Regeneration.

Authors:  Ephraim F Trakhtenberg; Yan Wang; Melina I Morkin; Stephanie G Fernandez; Gregory M Mlacker; Jesse M Shechter; Xiongfei Liu; Karan H Patel; Allison Lapins; Steven Yang; Susan M Dombrowski; Jeffrey L Goldberg
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

6.  Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity.

Authors:  R Pippa; A Dominguez; D J Christensen; I Moreno-Miralles; M J Blanco-Prieto; M P Vitek; M D Odero
Journal:  Leukemia       Date:  2014-04-30       Impact factor: 11.528

7.  Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease.

Authors:  Hitoshi Tanimukai; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

8.  Upregulation of SET expression by BACE1 and its implications in Down syndrome.

Authors:  Xiaozhu Zhang; Yili Wu; Xiaoling Duan; Wei Chen; Haiyan Zou; Mingming Zhang; Shuting Zhang; Fang Cai; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

9.  Yeast Nap1-binding protein Nbp2p is required for mitotic growth at high temperatures and for cell wall integrity.

Authors:  Kentaro Ohkuni; Asuko Okuda; Akihiko Kikuchi
Journal:  Genetics       Date:  2003-10       Impact factor: 4.562

10.  Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.

Authors:  Takamasa Ichijo; George P Chrousos; Tomoshige Kino
Journal:  Mol Cell Endocrinol       Date:  2007-11-17       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.